Abstract
Truncating mutations and homozygous deletions in the hSNF5/INI1/BAF47 subunit of human SWI/SNF complexes occur in most malignant rhabdoid tumors and some other malignancies. How loss of hSNF5 contributes to tumorigenesis remains unknown. Because the SWI/SNF subunit BRG1 is required for RB-mediated cell cycle arrest, we hypothesized that hSNF5 deficiency disrupts RB signaling. Here we demonstrate that unlike BRG1, hSNF5 deficient cells retain functional RB since ectopic expression of either p16ink4a or a constitutively active form of RB (PSM–RB) led to cell cycle arrest. To determine how hSNF5 loss might contribute to tumorigenesis, we used a retrovirus to introduce hSNF5 into multiple deficient cell lines. In all cases, re-expression inhibited colony formation and induced cell cycle arrest characterized by a flattened morphology. Flow cytometry revealed that these cells accumulated in G0/G1. Importantly, arrested cells exhibited strong induction of p16ink4a, hypophosphorylated RB, and down-regulation of cyclin A, suggesting that hSNF5 signals upstream of RB to induce growth arrest. Co-expression of SV40 T/t abolished hSNF5-induced G1arrest and activation of RB. Likewise, HPV-16 E7 was sufficient to partially overcome cell cycle arrest. These results suggest that hSNF5 loss is not equivalent to BRG1/BRM loss in human tumor cell lines. Furthermore, hSNF5-induced cell cycle arrest of deficient cells is mediated in part through activation of p16ink4a expression. These findings provide insight into mechanisms of hSNF5-mediated tumor suppression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Afshari CA, Vojta PJ, Annab LA, Futreal PA, Willard TB, Barrett JC . 1993 Exp. Cell Res. 209: 231–237
Alani RM, Young AZ, Shifflett CB . 2001 Proc. Natl. Acad. Sci. USA 98: 7812–7816
Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC . 1996 Proc. Natl. Acad. Sci. USA 93: 13742–13747
Alevizopoulos K, Vlach J, Hennecke S, Amati B . 1997 EMBO J. 16: 5322–5333
Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B . 1990 Science 249: 912
Bartek J, Bartkova J, Lukas J . 1997 Exp. Cell Res. 237: 1–6
Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M . 2002 Cancer Res. 62: 323–328
Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B . 1999 Cancer Res. 59: 74–79
Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Randazzo F, Metzger D, Chambon P, Crabtree G, Magnuson T . 2000 Mol. Cell 6: 1287–1295
Campisi J . 2001 Trends Cell. Biol. 11: S27–S31
Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV . 1999 Nature Genet. 22: 102–105
Dai CY, Enders GH . 2000 Oncogene 19: 1613–1622
DeCristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE . 2001 J. Cell. Physiol. 186: 136–145
DeCristofaro MF, Betz BL, Wang W, Weissman BE . 1999 Oncogene 18: 7559–7565
Dillar L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, Friend SH . 1990 Mol. Cell. Biol. 10: 5772–5781
Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH . 1993 Proc. Natl. Acad. Sci. USA 90: 11034–11038
Dunaief JL, Strober BE, Guha S, Kharvari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP . 1994 Cell 79: 119–130
Dyson N . 1998 Genes Dev. 12: 2245–2262
Garvin AJ, Re GG, Tarnowski BI, Hazen-Martin DJ, Sens DA . 1993 Am. J. Pathol. 142: 375–380
Goldstein S, Moerman EJ, Fuji S, Sobel BE . 1994 J. Cell. Physiol. 161: 571–579
Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W, Smith TW, Imbalzano AN, Jones SN . 2001 Mol. Cell. Biol. 21: 3598–3603
Holstege FC, Jennings EG, Wyrick JJ, Lee Ti, Hengartner CJ, Green MR, Golub TR, Lander ES, Young RA . 1998 Cell 95: 717–728
Huang H-JS, Yea J-K, Shew J-Y . 1988 Science 242: 1563–1566
Ito T, Yamauchi M, Nishina M, Yamamichi N, Mizutani T, Ui M, Murakami M, Iba H . 2001 J. Biol. Chem. 276: 2852–2857
Jacobs JJ, Kieboom K, Marino S, DePhino RA, van Lohuizen M . 1999 Nature 397: 164–168
Jiang H, Karnezis AN, Tao M, Guida PM, Zhu L . 2000 Oncogene 19: 3878–3887
Karnes PS, Tran TN, Cui MY, Bogenmann E, Shimada H, Ying KL . 1991 Cancer Genet. Cytogenet. 56: 31–38
Kingston RE, Narlikar GJ . 1999 Genes Dev. 13: 2339–2352
Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M . 2000 EMBO Rep. 1: 500–506
Knudsen ES, Buckmaster C, Chen TT, Feramisco JR, Wang JY . 1998 Genes Dev. 12: 2278–2292
Knudsen ES, Wang JY . 1997 Mol. Cell. Biol. 17: 5771–5783
Knudsen KE, Fribourg AF, Strobeck MW, Blanchard JM, Knudsen ES . 1999 J. Biol. Chem. 274: 27632–27641
Koh J, Enders GH, Dynlacht BD, Harlow E . 1995 Nature 375: 506–510
Laurent BC, Treitel MA, Carlson M . 1991 Proc. Natl. Acad. Sci. USA 88: 2687–2691
Litzkas P, Jha KK, Ozer HL . 1984 Mol. Cell. Biol. 4: 2549–2552
Lucibello FC, Sewing A, Brusselbach S, Burger C, Muller R . 1993 J. Cell. Sci. 105: 123–133
Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J . 1995 Nature 375: 503–506
Medema RH, Herrera RE, Lam F, Weinberg RA . 1995 Proc. Natl. Acad. Sci. USA 92: 6289–6293
Morgenstern JP, Land H . 1990 Nucleic Acids Res. 18: 3587–3596
Morisaki H, Ando A, Nagata Y, Pereira-Smith JR, Ikeda K, Nakanishi M . 1999 Exp. Cell Res. 253: 503–510
Mu XC, Higgins PJ . 1995 J. Cell Physiol. 165: 647–657
Munger K, Basile JR, Duesing S, Eichten A, Gonzalez SL, Grace M, Zacny VL . 2001 Oncogene 20: 7888–7898
Neely KE, Hassan AH, Brown CE, Howe L, Workman JL . 2002 Mol. Cell. Biol. 22: 1615–1625
Nie Z, Zue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W . 2000 Mol. Cell. Biol. 20: 8879–8888
Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E . 2001 Nature 409: 1067–1070
Ota S, Crabbe DCG, Tran TN, Triche TJ, Shimada H . 1993 Cancer 71: 2862–2872
Passegue E, Wagner EF . 2000 EMBO J. 19: 2969–2979
Peebles PT, Triche T, Papageorge AG . 1978 Pediatr. Res. 12: 485
Peterson CL, Herskowitz I . 1992 Cell 68: 573–583
Peterson CL, Workman JL . 2000 Curr. Opin. Genet. Dev. 10: 187–192
Phelan ML, Sif S, Narlikar GJ, Kingston RE . 1999 Mol. Cell 3: 247–253
Reisman DN, Strobeck MW, Beta BL, Sciariotta J, Funkhouser Jr W, Muchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE . 2002 Oncogene 21: 1196–1207
Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M . 1998 EMBO J. 17: 6979–6991
Robbins E, Levine EM, Eagle H . 1970 J. Exp. Med. 131: 1211–1222
Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH . 2000 Proc. Natl. Acad. Sci. USA 97: 13796–13800
Serrano M, Hannon GJ, Beach D . 1993 Nature 366: 704–707
Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . 1997 Cell 88: 593–602
Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O . 1999a Hum. Mol. Genet. 8: 2359–2368
Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O . 1999b Am. J. Hum. Genet. 65: 1342–1348
Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E . 1999 Mol. Cell. Biol. 19: 1460–1469
Sherr CJ . 1996 Science 274: 1672–1677
Sif S, Saurin AJ, Imbalzano AN, Kingston RE . 2001 Genes Dev. 15: 603–618
Smith JR, Pereira-Smith OM . 1996 Science 273: 63–67
Stein GH, Beeson M, Gordon L . 1990 Science 249: 666–669
Stein GH, Dulic V . 1995 Bioessays 17: 537–543
Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES . 2001 J. Biol. Chem. 276: 9273–9278
Strobeck MW, Fribourg AF, Puga A, Knudsen ES . 2000a Oncogene 19: 1857–1867
Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES . 2000b Proc. Natl. Acad. Sci. USA 97: 7748–7753
Strobeck MW, Reisman DN, Gunawardena RW, Betz BL, Angus SP, Knudsen KE, Kowalik TF, Weissman BE, Knudsen ES . 2002 J. Biol. Chem. 277: 4782–4789
Strober BE, Dunaief JL, Guha S, Goff SP . 1996 Mol. Cell. Biol. 16: 1576–1683
Sudarsanam P, Iyer VR, Brown PO, Winston F . 2000 Proc. Natl. Acad. Sci. USA 97: 3364–3369
Sullivan EK, Weirich CS, Guyon JR, Sif S, Kingston RE . 2001 Mol. Cell. Biol. 21: 5826–5837
Suzuki A, Ohta S, Shimada M . 1997 Diagn. Mol. Pathol. 6: 326–332
Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT . 2000 Am. J. Hum. Genet. 66: 1403–1406
Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T . 1997 Proc. Natl. Acad. Sci. USA 94: 11268–11273
Versteege I, Sevenet N, Lange J, Rosseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O . 1998 Nature 394: 203–206
Vignali M, Hassan AH, Neely KE, Workman JL . 2000 Mol. Cell. Biol. 20: 1899–1910
Wang W, Cote J, Xue Y, Zhou Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR . 1996 EMBO J. 15: 5370–5382
Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, Ghaffari S, Iliev D, Penn B, Woodland AM, Smith R, Salada G, Carillo A, Laity K, Gupte J, Swedlund B, Tavigian SV, Teng DH, Lees E . 2000 Cancer Res. 60: 6171–6177
Workman JL, Kingston RE . 1998 Annu. Rev. Biochem. 67: 545–579
Xue Y, Canman JC, Lee CS, Nie Z, Yang D, Moreno GT, Young MK, Salmon ED, Wang W . 2000 Proc. Natl. Acad. Sci. USA 97: 13015–13020
Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC . 2000 Cell 101: 79–89
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Betz, B., Strobeck, M., Reisman, D. et al. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1arrest associated with induction of p16ink4a and activation of RB. Oncogene 21, 5193–5203 (2002). https://doi.org/10.1038/sj.onc.1205706
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205706
Keywords
This article is cited by
-
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance
Nature Communications (2023)
-
Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells
Cancer Gene Therapy (2021)
-
SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features
Head and Neck Pathology (2021)
-
Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics
Journal of Neuro-Oncology (2020)
-
NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
BMC Cancer (2019)